Wells Fargo’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-23,021
| Closed | -$794K | – | 7040 |
|
|
2020
Q3 | $794K | Sell |
23,021
-196,148
| -89% | -$6.77M | ﹤0.01% | 3937 |
|
|
2020
Q2 | $3.66M | Buy |
219,169
+12,294
| +6% | +$205K | ﹤0.01% | 2733 |
|
|
2020
Q1 | $2.98M | Sell |
206,875
-33,520
| -14% | -$483K | ﹤0.01% | 2630 |
|
|
2019
Q4 | $8.05M | Buy |
240,395
+83,979
| +54% | +$2.81M | ﹤0.01% | 2144 |
|
|
2019
Q3 | $3.28M | Buy |
156,416
+101,491
| +185% | +$2.12M | ﹤0.01% | 2882 |
|
|
2019
Q2 | $1.14M | Sell |
54,925
-10,414
| -16% | -$217K | ﹤0.01% | 3713 |
|
|
2019
Q1 | $1.46M | Sell |
65,339
-9,864
| -13% | -$221K | ﹤0.01% | 3564 |
|
|
2018
Q4 | $1.8M | Buy |
75,203
+13,523
| +22% | +$323K | ﹤0.01% | 3310 |
|
|
2018
Q3 | $1.68M | Sell |
61,680
-765
| -1% | -$20.9K | ﹤0.01% | 3499 |
|
|
2018
Q2 | $1.68M | Sell |
62,445
-5,509
| -8% | -$148K | ﹤0.01% | 3551 |
|
|
2018
Q1 | $2.16M | Buy |
67,954
+4,796
| +8% | +$153K | ﹤0.01% | 3281 |
|
|
2017
Q4 | $2.39M | Buy |
63,158
+1,892
| +3% | +$71.5K | ﹤0.01% | 3191 |
|
|
2017
Q3 | $1.52M | Buy |
61,266
+2,025
| +3% | +$50.2K | ﹤0.01% | 3477 |
|
|
2017
Q2 | $1.22M | Sell |
59,241
-999
| -2% | -$20.5K | ﹤0.01% | 3526 |
|
|
2017
Q1 | $1.31M | Sell |
60,240
-3,448
| -5% | -$74.9K | ﹤0.01% | 3491 |
|
|
2016
Q4 | $1.3M | Buy |
63,688
+8,755
| +16% | +$179K | ﹤0.01% | 3442 |
|
|
2016
Q3 | $824K | Buy |
54,933
+3,454
| +7% | +$51.8K | ﹤0.01% | 3541 |
|
|
2016
Q2 | $558K | Sell |
51,479
-3,213
| -6% | -$34.8K | ﹤0.01% | 3761 |
|
|
2016
Q1 | $741K | Buy |
54,692
+47,985
| +715% | +$650K | ﹤0.01% | 3534 |
|
|
2015
Q4 | $124K | Buy |
6,707
+3,868
| +136% | +$71.5K | ﹤0.01% | 4593 |
|
|
2015
Q3 | $71K | Buy |
+2,839
| New | +$71K | ﹤0.01% | 4914 |
|